TERRI WASHINGTON: Open Payments
NPI 1114120722 · MELROSE PARK, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,907 in 29 payments from 13 companies in 2025. Trend: 2023 $11,350 · 2024 $2,111 · 2025 $2,907
Consulting: $2,130Food & beverage: $777
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $2,421 |
| Amgen Inc. | 2 | $167 |
| RECORDATI_RARE_DISEASES_INC. | 4 | $101 |
| Corcept Therapeutics | 2 | $35 |
| Ascendis Pharma Endocrinology Inc | 1 | $27 |
| Sequel Med Tech, LLC | 1 | $26 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24 |
| IBSA Pharma Inc. | 1 | $21 |
| Tandem Diabetes Care, Inc. | 1 | $20 |
| Insulet Corporation | 1 | $17 |
Products named: Rybelsus, Wegovy, TEPEZZA, ISTURISA, Korlym, Yorvipath, TWIIST, JARDIANCE.
Industry payments across IL — which companies pay providers there.
